<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04133168</url>
  </required_header>
  <id_info>
    <org_study_id>PY004</org_study_id>
    <nct_id>NCT04133168</nct_id>
  </id_info>
  <brief_title>Boston Scientific's Cryoballoon in the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation</brief_title>
  <acronym>FROZEN-AF</acronym>
  <official_title>Safety and Effectiveness IDE Trial for Boston Scientific's Cryoballoon in the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To establish the safety and effectiveness of the Boston Scientific Cardiac Cryoablation&#xD;
      System for treatment of symptomatic, drug refractory, recurrent, paroxysmal atrial&#xD;
      fibrillation (AF).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Multi-center, open label, prospective, single arm study to document the safety and&#xD;
      performance of Boston Scientific's Cryoablation System. The Cryoablation System is intended&#xD;
      for cryoablation and electrical mapping of the pulmonary veins for pulmonary vein isolation&#xD;
      (PVI) in the ablation treatment of patients with paroxysmal atrial fibrillation (PAF). All&#xD;
      subjects fitting the enrollment criteria, signing the consent and undergoing the index&#xD;
      procedure with the study devices will be followed up for twelve (12) months after the index&#xD;
      procedure.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 24, 2020</start_date>
  <completion_date type="Anticipated">September 23, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 23, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>open label, prospective, single arm study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of Primary Safety Events at 12 Months post-procedure (acute and chronic events)</measure>
    <time_frame>12 Months</time_frame>
    <description>composite of procedure-related and device-related adverse events. 7 days (Death, Myocardial infarction, Transient ischemic attack, Stroke/ Cerebrovascular accident, Vascular access complications, Mitral or tricuspid valvular damage, Thromboembolism/ Air embolism leading to a life-threatening event such as a ventricular arrhythmia, stroke, pulmonary embolism, or myocardial infarction and, thromboembolic events that result in permanent injury, require intervention for treatment or prolongs or require hospitalization for more than 48 hours, Gastroparesis/injury to vagus nerve, Pneumothorax, Pulmonary edema/heart failure AV block); 30 days (Cardiac tamponade/perforation); 12 months: (Atrial esophageal fistula, Severe Pulmonary vein stenosis, Persistent phrenic nerve palsy .</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Freedom from Treatment Failure at 12 Months post-procedure.</measure>
    <time_frame>12 Months</time_frame>
    <description>freedom from the composite of: 1)Failure to achieve acute procedural success in the index procedure or repeat procedure during the blanking period; 2 Use of amiodarone post index procedure; 3 Surgical treatment for AF/AFL/AT post index procedure; 4) Use of a non-study ablation catheter for AF targets in the index procedure or repeat procedure during the blanking period; 5) More than one repeat procedure with the POLARx catheter during the blanking period (90 days post index procedure); 6) Documented atrial fibrillation, or new onset of atrial flutter or atrial tachycardia event between days 91 and 365 days post index procedure; 7) Any of the following interventions for atrial fibrillation, or new onset of atrial flutter or atrial tachycardia between days 91 post index procedure and 365 days:Repeat procedure - Electrical and/or pharmacological cardioversion for AF/AFL/AT - Prescribed any antiarrhythmic drug (AAD)*</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of Acute Procedural Success defined as the achievement of electrical isolation of all PVs by using the Cardiac Cryoablation system</measure>
    <time_frame>1 day</time_frame>
    <description>the achievement of electrical isolation of all PVs by using the POLARx Cardiac Cryoablation system only. Electrical isolation of a PV is demonstrated by entrance and exit block.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of reportable Adverse Events at 12 months</measure>
    <time_frame>12 months</time_frame>
    <description>All Serious Adverse Events&#xD;
All Study Procedure-Related Adverse Events&#xD;
All Study Device-Related Adverse Events&#xD;
All Study Device Deficiencies&#xD;
Unanticipated Adverse Device Effects/Unanticipated Serious Adverse Device Effects previously not defined in Investigator's Brochure or DFU</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">405</enrollment>
  <condition>Paroxysmal Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Cryoablation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects undergoing cardiac ablation procedure with the POLARx™ Cardiac Cryoablation System</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>POLARx™ Cardiac Cryoablation System</intervention_name>
    <description>The POLARx Cardiac Cryoablation System is intended for ablation and electrical mapping of the pulmonary veins for pulmonary vein isolation (PVI) in the ablation treatment of patients with paroxysmal atrial fibrillation (PAF).The system consists of the following devices and components:&#xD;
POLARx™ Cryoablation Catheter&#xD;
POLARMAP™ Catheter&#xD;
POLARSHEATH™&#xD;
SMARTFREEZE™ Console&#xD;
Diaphragm Movement Sensor (DMS)&#xD;
Related Accessories</description>
    <arm_group_label>Cryoablation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  History of recurrent symptomatic paroxysmal atrial fibrillation (PAF), defined as&#xD;
             atrial fibrillation that terminates spontaneously or with intervention (either&#xD;
             procedure or drug therapy) within seven days of onset. Minimum documentation includes&#xD;
             the following:&#xD;
&#xD;
               -  a physician's note indicating recurrent self-terminating atrial fibrillation (AF)&#xD;
                  which includes at least two symptomatic AF episodes within six months prior to&#xD;
                  enrollment, and one electrocardiographically documented AF episode within 12&#xD;
                  months prior to enrollment.&#xD;
&#xD;
          -  No amiodarone use within 90 days prior to enrollment;&#xD;
&#xD;
          -  Subjects who are indicated for an ablation procedure for paroxysmal atrial&#xD;
             fibrillation (PAF) according to 2017 HRS expert consensus statement on catheter and&#xD;
             surgical ablation of atrial fibrillation;&#xD;
&#xD;
          -  Subjects refractory or intolerant to at least one class I or III antiarrhythmic&#xD;
             medication;&#xD;
&#xD;
          -  Subjects who are willing and capable of providing informed consent;&#xD;
&#xD;
          -  Subjects who are willing and capable of participating in all testing associated with&#xD;
             this clinical investigation at an approved clinical investigational center;&#xD;
&#xD;
          -  Subjects whose age is 18 years or above, or who are of legal age to give informed&#xD;
             consent specific to state and national law.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any known contraindication to an AF ablation or anticoagulation;&#xD;
&#xD;
          -  Continuous AF lasting longer than seven (7) days from onset;&#xD;
&#xD;
          -  History of previous left atrial ablation or surgical treatment for AF/ AFL/ AT;&#xD;
&#xD;
          -  Atrial fibrillation secondary to electrolyte imbalance, thyroid disease, or any other&#xD;
             reversible or non-cardiac cause;&#xD;
&#xD;
          -  Structural heart disease or implanted devices as described below:&#xD;
&#xD;
               1. Left ventricular ejection fraction (LVEF) &lt; 40% based on the most recent&#xD;
                  transthoracic echocardiogram (TTE) (≤180 days prior to enrollment);&#xD;
&#xD;
               2. Left atrial diameter &gt; 55 mm OR left atrial volume &gt; 50 ml/m2 ml indexed based on&#xD;
                  the most recent TTE (≤ 180 days prior to enrollment);&#xD;
&#xD;
               3. An implanted pacemaker, ICD, CRT device or an arrhythmia loop recorder;&#xD;
&#xD;
               4. Previous cardiac surgery: i.e. ventriculotomy or atriotomy (excluding atriotomy&#xD;
                  for CABG);&#xD;
&#xD;
               5. Previous cardiac valvular surgical or percutaneous procedure, or prosthetic&#xD;
                  valve, including mitral valve clips;&#xD;
&#xD;
               6. Interatrial baffle, closure device, patch, or patent foramen ovale (PFO) occlude;&#xD;
&#xD;
               7. Presence of a left atrial appendage occlusion device;&#xD;
&#xD;
               8. Presence of any pulmonary vein stents;&#xD;
&#xD;
               9. Coronary artery bypass graft (CABG), PTCA/ PCI/ coronary stent procedures within&#xD;
                  90 days prior to enrollment;&#xD;
&#xD;
              10. Unstable angina or ongoing myocardial ischemia;&#xD;
&#xD;
              11. myocardial infarction within 90 days prior to enrollment;&#xD;
&#xD;
              12. Moderate or severe mitral insufficiency assessed on the most recent TTE (≤180&#xD;
                  days prior to enrollment, e.g. pulmonary artery pressure &gt;30 mmHg);&#xD;
&#xD;
              13. Evidence of left atrial thrombus;&#xD;
&#xD;
          -  Any previous history of cryoglobulinemia;&#xD;
&#xD;
          -  Stage 3B or higher renal disease (estimated glomerular filtration rate, eGFR &lt;45&#xD;
             mL/min);&#xD;
&#xD;
          -  History of blood clotting or bleeding disease;&#xD;
&#xD;
          -  Any prior history of documented cerebral infarct, TIA or systemic embolism [excluding&#xD;
             a post-operative deep vein thrombosis (DVT)] ≤180 days prior to enrollment;&#xD;
&#xD;
          -  Active systemic infection;&#xD;
&#xD;
          -  Pregnant, lactating (current or anticipated during study follow up), or women of&#xD;
             childbearing potential who are, or plan to become, pregnant during the time of the&#xD;
             study (method of assessment upon physician's discretion);&#xD;
&#xD;
          -  Subjects who are currently enrolled in another investigational study or registry that&#xD;
             would directly interfere with the current study, except when the subject is&#xD;
             participating in a mandatory governmental registry, or a purely observational registry&#xD;
             with no associated treatments; each instance must be brought to the attention of the&#xD;
             sponsor to determine eligibility;&#xD;
&#xD;
          -  Subjects who in the judgment of the investigator have a life expectancy of less than&#xD;
             two years.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kenneth Ellenbogen, MD</last_name>
    <role>Study Chair</role>
    <affiliation>VCU Pauley Heart Center, Richmond, Virginia, USA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Arash Aryana, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mercy General Hospital,Sacramento, CA , USA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nassir Marrouche, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Utah School of Medicine. Slat Lake City, UT, USA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ante Anić, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Split, Croatia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Suneet Mittal, MD,FACC,FHRS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Snyder AF Center, New York, NY, USA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Niraj Varma, MD,PhD,FRCP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cleveland Clinic, Cleveland OH, USA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wilber W Su, MD,FACC,FHRS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Banner- University Medical Group- Heart Center, Phoenix, AZ, USA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Banner University Medical Center</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85006</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pima Heart and Vascular</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85712</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arrhythmia Research Group</name>
      <address>
        <city>Jonesboro</city>
        <state>Arkansas</state>
        <zip>72401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cedars - Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy General Hospital</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95819</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Torrance Memorial Medical Center</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90505</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tallahassee Memorial Hospital</name>
      <address>
        <city>Tallahassee</city>
        <state>Florida</state>
        <zip>32308</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AdventHealth Tampa</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33613</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Hospital</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33614</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30308</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southcoast Physicians Group</name>
      <address>
        <city>Fall River</city>
        <state>Massachusetts</state>
        <zip>02720</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Luke's Hospital of Kansas City</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Valley Hospital</name>
      <address>
        <city>Ridgewood</city>
        <state>New Jersey</state>
        <zip>07450-2736</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwell Health</name>
      <address>
        <city>Staten Island</city>
        <state>New York</state>
        <zip>10305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Hospital Health Center</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kettering Medical Center</name>
      <address>
        <city>Kettering</city>
        <state>Ohio</state>
        <zip>45429</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>York Hospital</name>
      <address>
        <city>York</city>
        <state>Pennsylvania</state>
        <zip>17403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stern Cardiovascular Foundation, Inc.</name>
      <address>
        <city>Germantown</city>
        <state>Tennessee</state>
        <zip>38138</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor Heart &amp; Vascular Hospital</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Christus Trinity Mother Frances Health System</name>
      <address>
        <city>Tyler</city>
        <state>Texas</state>
        <zip>75702</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chippenham &amp; Johnston-Willis Hospital</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23225</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University Health System</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PeaceHealth Southwest Medical</name>
      <address>
        <city>Vancouver</city>
        <state>Washington</state>
        <zip>98664</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Mary's Medical Center</name>
      <address>
        <city>Huntington</city>
        <state>West Virginia</state>
        <zip>25702</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aurora Health Care</name>
      <address>
        <city>Grafton</city>
        <state>Wisconsin</state>
        <zip>53024</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UZ Brussels</name>
      <address>
        <city>Brussels</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hamilton General Hospital</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8L 2X2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut de Cardiologie de Montreal</name>
      <address>
        <city>Montreal</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut universitaire de Cardiologie et de Pneumologie de Quebec</name>
      <address>
        <city>Quebec</city>
        <zip>G1V 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vancouver General Hospital</name>
      <address>
        <city>Vancouver</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Grenoble - Hopital Michallon</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herz-und Diabeteszentrum Nordrhein-Westfalen</name>
      <address>
        <city>Bad Oeynhausen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Schleswig-Holstein</name>
      <address>
        <city>Lübeck</city>
        <zip>D-23538</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Queen Mary Hospital</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prince of Wales Hospital</name>
      <address>
        <city>Sha Tin</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maria Cecilia Hospital SPA</name>
      <address>
        <city>Cotignola</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Erasmus MC- University Medical Center Rotterdam</name>
      <address>
        <city>Rotterdam</city>
        <zip>3015 CE</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Taipei Veterans General Hospital</name>
      <address>
        <city>Taipei</city>
        <state>Beitou District</state>
        <zip>11217</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei City</city>
        <state>Zhongzheng Dist</state>
        <zip>10002</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Canada</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hong Kong</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Taiwan</country>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 3, 2019</study_first_submitted>
  <study_first_submitted_qc>October 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 21, 2019</study_first_posted>
  <last_update_submitted>November 1, 2021</last_update_submitted>
  <last_update_submitted_qc>November 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cryoablation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No requests for study data have been made at this time, however Boston's Scientific's policy on data sharing can be found at http://www.bostonscientific.com/en-US/data-sharing-requests.html</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

